This site is intended for Healthcare professionals only.

Zika no threat to plasma derived drugs, says EU regulator


Zika no threat to plasma derived drugs, says EU regulator

London : Patients who take medicines derived from blood plasma or urine are not at increased risk of catching Zika, even if the body fluids come from countries where the virus is prevalent, Europe’s drugs regulator said.

Plasma derived products are used to treat some serious blood conditions and to help fight infections, while urine-based medicines include certain hormone treatments and therapies to help break up blood clots.

The European Medicines Agency, Europe’s equivalent of the U.S. Food and Drug Administration (FDA), said its experts had assessed the risks and concluded that manufacturing processes used for such products would inactivate or remove the Zika virus.

This includes the use of solvents or detergents, pasteurisation and filtration.

Health authorities are currently taking extra care with whole blood donations. Last month, the FDA recommended that all blood donations be tested for Zika in a drive to prevent transmission of the virus through the blood supply.

The following two tabs change content below.
supriya kashyap

supriya kashyap

Supriya Kashyap Joined Medical Dialogue as Reporter in 2015 . she covers all the medical specialty news in different medical categories. She also covers the Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in medical filed. She is a graduate from Delhi University. She can be contacted at supriya.kashyap@medicaldialogues.in Contact no. 011-43720751
Source: Reuters

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted